Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 8/2018

01-08-2018 | Letter

Insights uncovered from experiencing a rise in the incidence of gestational diabetes at a Melbourne hospital. Reply to Ng E, Neff M, Sztal-Mazer S [letter]

Authors: Sarah H. Koning, Jelmer J. van Zanden, Klaas Hoogenberg, Helen L. Lutgers, Alberdina W. Klomp, Fleurisca J. Korteweg, Aren J. van Loon, Bruce H. R. Wolffenbuttel, Paul P. van den Berg

Published in: Diabetologia | Issue 8/2018

Login to get access

Excerpt

To the Editor: We thank Elisabeth Ng and colleagues for their interest in our paper and confirmation of our data [1]. It was interesting to read their experiences with the rising incidence of gestational diabetes mellitus (GDM) in a multi-ethnic, metropolitan maternity hospital in Melbourne (Australia) after implementing the new diagnostic criteria [2]. …
Literature
1.
Koning SH, van Zanden JJ, Hoogenberg K et al (2018) New diagnostic criteria for gestational diabetes mellitus and their impact on the number of diagnoses and pregnancy outcomes. Diabetologia 61:800–809CrossRefPubMed
2.
3.
Farrar D, Fairley L, Santorelli G et al (2015) Association between hyperglycaemia and adverse perinatal outcomes in South Asian and white British women: analysis of data from the Born in Bradford cohort. Lancet Diabetes Endocrinol 3:795–804CrossRefPubMedPubMedCentral
4.
Koning SH, Lutgers HL, Hoogenberg K et al (2016) Postpartum glucose follow-up and lifestyle management after gestational diabetes mellitus: general practitioner and patient perspectives. J Diabetes Metab Disord 15:56CrossRefPubMedPubMedCentral
5.
Chu SY, Callaghan WM, Kim SY et al (2007) Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 30:2070–2076CrossRefPubMed
6.
Torloni M, Betrán A, Horta B et al (2009) Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 10:194–203CrossRefPubMed
7.
Dodd JM, Grivell RM, Nguyen A, Chan A, Robinson JS (2011) Maternal and perinatal health outcomes by body mass index category. Aust N Z J Obstet Gynaecol 51:136–140CrossRefPubMed
Metadata
Title
Insights uncovered from experiencing a rise in the incidence of gestational diabetes at a Melbourne hospital. Reply to Ng E, Neff M, Sztal-Mazer S [letter]
Authors
Sarah H. Koning
Jelmer J. van Zanden
Klaas Hoogenberg
Helen L. Lutgers
Alberdina W. Klomp
Fleurisca J. Korteweg
Aren J. van Loon
Bruce H. R. Wolffenbuttel
Paul P. van den Berg
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4667-2

Other articles of this Issue 8/2018

Diabetologia 8/2018 Go to the issue

Article

Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial

Up Front

Up front

Article

The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice

Article

Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes

Article

Genetic variants of gestational diabetes mellitus: a study of 112 SNPs among 8722 women in two independent populations

Article

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits